70
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients

, &
Pages 2421-2423 | Received 25 Apr 2006, Accepted 29 May 2006, Published online: 01 Jul 2009

References

  • Zuckerman E, Zuckerman T, Levine A M, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423–428
  • Ferri C, Caracciolo F, Zignego A L, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392–394
  • Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo M G, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-center case-control study. Blood 2003; 102: 996–999
  • Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004; 111: 1–8
  • Gisbert J P, Garcia-Buey L, Pajares J M, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723–1732
  • Besson C, Canioni D, Lepage D, Pol S, Morel P, Lederlin P, et al. Characteristics and outcome of diffuse B-cell lymphoma in hepatitis C-virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adult programs. J Clin Oncol 2006; 24: 953–960
  • Hamblin T J. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006; 33: 230–239
  • Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M, Masauzi N. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 2005; 4: 599–608
  • Caligaris-Cappio F, De Leo A M, Bertero M T. Autoimmune phenomena and hepatitis C virus in lymphoproliferative and connective tissue disorders. Leuk Lymphoma 1997; 28: 57–63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.